Tag: fda

FDA Considering Independent Evaluation for DNA Contamination in COVID-19 Vaccines

The Food and Drug Administration is mulling over conducting its own evaluation of the levels of DNA in COVID-19 vaccines, an FDA official has disclosed.

“I’ll say that that is something that’s being discussed,” Dr. Tracy Hoeg, a senior adviser to the FDA’s commissioner, told members of the Centers for Disease Control and Prevention’s vaccine advisory panel on Sept. 19.

Before the panel’s members unanimously recommended during the meeting that the CDC roll back COVID-19 vaccine recommendations, a number expressed concerns about growing evidence of higher-than-allowed levels of DNA in the vaccines, the spreadofthevaccinebeyond the injection site, and the long-term persistence of messenger ribonucleic acid (mRNA)—a key part of the Pfizer-BioNTech and Moderna shots.

The CDC has described mRNA as the entity teaching cells how to make copies of the spike protein to enable protection when the real virus, with its own spike protein, attacks the body. “After the mRNA delivers the instructions, your cells break it down and get rid of it,” a CDC graphic states.

Retsef Levi, chair of the advisory panel’s COVID-19 immunization workgroup, showed the graphic during the meeting.

“We have a range of things on the mRNA platforms that really suggests that it doesn’t work as intended,” Levi said, citing issues such as the spread of spike protein and mRNA into various parts of the body and “DNA contamination.”

Keep reading

FDA Warns Companies Against False and Misleading Drug Ads

Federal regulators sent dozens of letters to companies in September warning them that their advertisements for drugs are misleading and could lead to repercussions unless fixed.

The Food and Drug Administration on Sept. 16 released 65 letters it sent on Sept. 9 to companies, including Eli Lilly and Novo Nordisk. President Donald Trump signed a memorandum that day directing officials to enforce existing rules surrounding direct-to-consumer advertising for drugs.

In letters to Eli Lilly, FDA officials said that advertisements for weight loss products, including one that originally appeared in a special held by Oprah Winfrey, did not present people with accurate information about possible side effects.

The ad that aired during the Oprah special “creates a misleading impression regarding the safety of Zepbound and Mounjaro, which are drugs with multiple serious, potentially life threatening risks,” officials with the FDA’s Center for Drug Evaluation and Research said in one of the letters. They said that people who seek medical treatment for obesity or Type 2 diabetes “should receive truthful and non-misleading information.”

An Eli Lilly spokesperson told The Epoch Times in an email: “FDA’s correspondence to Lilly addresses three interviews conducted by independent media outlets. These interviews were not advertisements, and Lilly had no editorial control over them.

“We remain committed to providing patients with accurate, reliable information that empowers them to make informed healthcare decisions in partnership with their physicians.”

Keep reading

FDA targets Hims & Hers, posts more than 100 letters to drugmakers

The Trump administration is cracking down on pharmaceutical advertising and they are specifically targeting telehealth companies that promote unofficial versions of weight loss medications.

More than 100 letters were posted by the Food and Drug Administration to drugmakers and online prescribing companies. Hims & Hers built a multibillion-dollar business around weight loss interventions. The letters warned the companies, including Hims & Hers, to remove “false and misleading ” promotional statements and advertising from their website.

Your claims imply that your products are the same as an FDA-approved product when they are not,” states the warning letter, dated Sept. 9.

Hims said Tuesday that it “looks forward to engaging with the FDA.”

“Our website and our customer-facing materials note that compounded treatments are not approved or evaluated by the FDA,” the company said in a statement.

Keep reading

Trump FDA to Present Data Linking COVID Jabs to Child Deaths at Upcoming CDC Meeting

The Food and Drug Administration (FDA) will present data linking COVID-19 vaccines to the deaths of dozens of children.

According to several media reports, the CDC’s Advisory Committee on Immunization Practices (ACIP) will meet Thursday and Friday to review and recommend several vaccines, including this fall’s updated Covid shots.

The FDA is basing its claim on data from the Vaccine Adverse Event Reporting System (VAERS), a public database run jointly by the FDA and CDC.

The reports come after FDA Commissioner Marty Makary told CNN last week that the agency is investigating reports of healthy children dying after receiving Covid vaccines.

“We’ve been looking into the VAERS database of self-reports that there have been children that have died from the Covid vaccine,” Makary said.

“We’re going to release a report in the coming few weeks and we’re going to let people know. We’re doing an intense investigation.”

Keep reading

FDA Chief Says No Solid Evidence Supporting Hepatitis B Vaccine At Birth

The head of the Food and Drug Administration said on Sept. 8 that there is no strong evidence supporting the administration of a hepatitis B vaccine to infants.

“I personally don’t believe that the evidence is solid to say the Hep B shot needs to be given at birth,” Dr. Marty Makary, the FDA commissioner, said during an appearance on Fox News.

“It’s totally different from polio and measles, and some of these other shots that are tried and true and have been around for a long time.”

The FDA, which is part of the Department of Health and Human Services, has cleared hepatitis B vaccines to be administered at birth. The Centers for Disease Control and Prevention recommends that all infants receive a hepatitis B vaccine on the day they are born.

A debate among some doctors regarding the recommendation has been taking place in light of the CDC vaccine advisory panel’s scheduled discussion on the hepatitis B vaccination at its upcoming meeting.

“I predict that what they’re going to do is try to change the birth dose of hepatitis B vaccine so that kids don’t get it when they’re born,” Dr. Demetre Daskalakis, who recently resigned from the CDC, said during an appearance on ABC.

The panel makes recommendations on vaccines. The recommendations are usually adopted by the CDC.

Hepatitis B is a liver infection that can lead to liver failure and death, although some of those infected never experience symptoms. Hepatitis B is contracted through contact with the bodily fluids of an infected person. Babies who are born to infected women can also contract it.

The CDC first recommended the hepatitis B vaccine in 1982, the year after it was cleared, for people deemed to be at high risk, such as drug users, pregnant women, and infants born to mothers who had hepatitis B.

By 1992, the recommendation for infants shifted to the first day of life and was broadened to all newborns because of “the difficulty of vaccinating high-risk adults,” according to the CDC.

Three doses of the vaccine are on the CDC’s childhood immunization schedule, and nearly every state requires hepatitis B vaccination to attend school and/or childcare facilities.

The stated goal of the vaccination campaign was to eliminate transmission of hepatitis B, which has not happened.

“We’re giving about 11 million doses of hepatitis B a year, and pretty much all of them are for kids who we know don’t need it,” since their mothers have been screened, Dr. Monique Yohanan, a senior fellow at Independent Women’s Forum, told The Epoch Times in a recent interview.

Keep reading

New York Health Dept Defies FDA: Hochul’s Emergency Order Pushes Off-Label COVID Shots For Kids As Young as 3

New York’s department of public health released a series of odd guidances to pharmacists and physicians on Friday to promote COVID vaccines to children and adults for “off label” use, meaning in conflict with FDA’s official label. Signed by Governor Kathy Hochul, New York’s executive order 52 declares a “disaster in the state of New York due to federal actions related to vaccine access.”

“A friend of mine said they’re contacting the nurse’s union,” a New York City nurse texted me, shortly after New York released their new COVID vaccine guidance. “They don’t know wtf to do with that!”

A New York physician sent me documents the state’s health department sent to physicians and pharmacists, called “providers” in healthcare lingo. She and the majority of her colleagues no longer get COVID boosters, and she’s worried that the new guidance for “off label” use makes no sense, does not fully inform patients, and might be illegal.

Pfizer pled guilty to criminal charges and paid a record $2.3 billion fine for illegal, off label promotion of multiple drugs in 2009. As previously reported here, Biden’s FDA Commissioner and CDC Director both promoted COVID vaccines for uses that the FDA admitted were off label. No evidence exists that pharmaceutical companies helped to shape New York’s off label policy, but CNBC reported in 2021 that Governor Hochul’s daughter-in-law is a top lobbyist at a pharma firm that has sought to influence NY lawmakers.

Keep reading

FDA Official Pressures YouTube Into Removing a Channel For Posting His Own Vaccine Comments

Last week, a top official with the Food and Drug Administration (FDA) apparently filed a bogus copyright claim to get a critic’s YouTube account taken down. This is an inappropriate act of censorship that, not long ago, conservatives would rightly have stood against.

“Jonathan Howard, a neurologist and psychiatrist in New York City, received an email from YouTube on Friday night, which stated that Vinay Prasad, who is the FDA’s top vaccine regulator, had demanded the removal of six videos of himself from Howard’s YouTube channel,” The Guardian reported this week. “Howard’s entire channel has now been deleted by YouTube, which cited copyright infringement.”

On his channel, Howard hosted videos of public health officials—including Prasad, Department of Health and Human Services Secretary Robert F. Kennedy Jr., and National Institutes of Health Director Jay Bhattacharya—making statements during the COVID-19 pandemic that turned out to be untrue or overly myopic. “I had accumulated about 350 videos, almost all of which were short clips of famous doctors saying absurd things,” Howard wrote in a blog post, “that herd immunity had arrived in the spring of 2021 and that RFK Jr. was an honest broker about vaccines, for example.” Howard is also critical of Prasad’s stance on vaccines, which Prasad now has the authority to regulate.

According to an email Howard posted, YouTube “terminated” his channel after “multiple copyright strikes” against his videos, and the “removal request” came from Prasad.

“Publishing someone else’s videos without modification or commentary is a clear copyright violation,” an FDA spokesperson told The Guardian. “The mission of Johnathan Howard was not medical transparency, but personal profit by grifting and stealing someone else’s intellectual property.”

“My YouTube channel had 256 subscribers and its videos were typically seen by dozens of people,” Howard wrote. “I never promoted the channel and made no money from it.” Besides, U.S. law allows for fair use of copyrighted material, which means someone can use protected content for purposes such as “criticism, comment, news reporting,” or “research” without the creator’s permission.

Howard is the author of the book We Want Them Infected, which criticized doctors and public health officials who advocated a herd immunity strategy for dealing with COVID-19. Howard says such warnings fed into anti-vaccine conspiracy theories. His YouTube channel collected videos of people who are now in charge of public health institutions, making what he feels were irresponsible claims during the pandemic.

But whether you agree with Howard or not, it is wrong and hypocritical for Prasad to silence his critics in this way.

Keep reading

FDA Revokes Emergency Authorization For COVID-19 Vaccines

The Department of Health and Human Services under Health Secretary Robert F. Kennedy Jr. revoked emergency authorization for COVID-19 vaccines.

“The emergency use authorizations for Covid vaccines, once used to justify broad mandates on the general public during the Biden administration, are now rescinded,” Kennedy posted to X on Wednesday.

The news comes as the FDA, which is part of HHS, announced the approval of the Pfizer-BioNTech COVID-19 vaccine for older adults and children as young as 5-years-old who have at least one condition that puts them at higher risk of severe COVID-19 outcomes, Pfizer said in a Wednesday statement.  

Regulators have issued similar approvals for COVID-19 jabs from Novavax and Moderna. 

HHS revoking emergency approval means that FDA clearance is no longer in place for some 240 million Americans, however “These vaccines are available for all patients who choose them after consulting with their doctors,” Kennedy sai. 

As the Epoch Times notes further, per federal law, the FDA approves products it determines are “safe, pure, and potent.” Emergency authorizations, in contrast, can only be offered under certain circumstances, such as during a public health emergency, and are for products that officials believe “may be effective” in treating or preventing a life-threatening disease or condition.

Updated Approvals

Dr. Marty Makary, the FDA’s commissioner, and Dr. Vinay Prasad, its top vaccine official at the time, signaled the change in May, when they said that the FDA would stop approving COVID-19 vaccines for many Americans absent clinical trial data.

“The FDA can only approve products if it concludes, based on scientific evidence, that the benefit-to-harm balance is favorable. And we simply need more data to have that confidence for younger individuals at low-risk of severe disease,” Prasad said at the time.

In the United States, regulators in recent years have been authorizing updated COVID-19 vaccines annually in a bid to counter waning effectiveness and better match circulating variants. The model is based on the historical approach to influenza vaccines.

Regulators in 2024 cleared updated shots from Moderna, Pfizer, and Novavax without human data, citing animal tests and data from trials for previous versions.

Keep reading

FDA Suspends License For Chikungunya Vaccine After ‘Serious Adverse Events’

Federal regulators on Aug. 25 said they’ve suspended approval for a vaccine against chikungunya, a mosquito-borne virus.

Due to reports of serious adverse events following administration of the vaccine, the Food and Drug Administration’s Center for Biologics Evaluation and Research (CBER) “believes this vaccine is not safe and that continued administration to the public would pose a danger to health,” the FDA said in a statement.

France-based Valneva makes the vaccine, known as Ixchiq.

“As we determine potential next steps, and as the clear threat of chikungunya continues to escalate globally, Valneva remains fully committed to maintaining access to our vaccine as a global health tool for addressing and preventing outbreaks of this devastating illness,” Thomas Lingelbach, Valneva’s CEO, said in a statement.

Zachart Stieber reports for The Epoch Times that the FDA originally approved Ixchiq in 2023 to prevent disease caused by the chikungunya virus in adults deemed to have an increased risk of exposure. The Centers for Disease Control and Prevention in 2024 recommended the vaccine for people traveling to certain countries.

Health officials said in an alert in May that they were advising a pause in administering the vaccine to elderly adults due to reports that some of those vaccinated had been experiencing serious adverse events (SAEs), including neurologic and cardiac problems.

This included 38 SAE reports for 32 unique cases (7 U.S., 25 foreign), including 21 hospitalizations and three deaths.

After CBER Director Dr. Vinay Prasad resigned, the FDA, in early August, ended the recommended suspension, stating that an updated assessment of risks and benefits for Ixchiq showed the benefits still outweighed the risks for some people.

In the new announcement, regulators said that is no longer the case.

The latest risk-benefit assessment includes four new foreign reports that came to light since the FDA lifted the recommended pause, including a report of problems following vaccination in a 55-year-old male.

Prasad said in a memorandum dated Aug. 22 that of the 32 cases, five tested positive for the vaccine strain of the virus, making it nearly certain that the vaccine caused the problem.

“There are reasonable grounds to believe the risks of the vaccine outweigh its benefits, and that it poses a danger to health. Therefore, CBER is suspending approval,” Prasad said.

Keep reading

The Case of the Damning FDA Memos

On July 21, 2025, the Informed Consent Action Network (ICAN) announced that it had secured the release of over 600,000 pages of Emergency Use Authorization (EUA) data used by the US Food and Drug Administration (FDA) to authorize and approve Pfizer-BioNTech’s COVID-19 vaccine (BNT162b2), following a successful lawsuit, culminating in a late 2024 court ruling.

These documents, now publicly available on ICAN’s website, are part of a broader release of over 1.6 million pages, including data from the vaccine’s licensure in August 2021 and the earlier EUA in December 2020.

This report builds on my prior investigative work analyzing thousands of FDA documents released following the Public Health and Medical Professionals for Transparency (PHMPT) lawsuit, which focused on the biological product file submitted by Pfizer for the full approval of its COVID-19 vaccine in August 2021.

I was one of the initial researchers to uncover and analyse the damning data hidden within Pfizer’s Pregnancy & Lactation Cumulative Review, Interim-Narrative-Sensitive document (3000+ pages), and Cumulative Analysis of Post-Authorization Adverse Event Reports document, among others.

Both ICAN and PHMPT’s lawsuits sought to make public the FDA’s data on the Pfizer-BioNTech’s COVID-19 shot, asserting that transparency is critical for public trust and independent analysis, given the global administration of billions of doses of this experimental gene-based product that was mandated in several countries.

My preliminary review of ICAN’s EUA data reveals several irregularities, outlined below with references to key documents and downloadable sources. This report focuses on four critical issues: manufacturing oversight gaps, missing Bell’s palsy data, clinical trial site deficiencies, and the exclusion of unconfirmed COVID-19 cases.

Keep reading